Dugel Pravin
Transaction: 06/16/2026
BUY
Change
+50,092
Price
Not reported
Filing
06/18/2026
Type
BUY
Ocular Therapeutix, Inc.
OCUL • Biotechnology
$10.64
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.39B
Growth
40.3%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.12Healthy liquidity · 15.39Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$10.64
Change0.00%
Shares Out224.95M
Market Cap$2.39B
Enterprise Value$1.87B
52W Range6.23 - 16.44
Beta0.94
P/E-7.94
P/S45.98
P/B4.60
P/FCF-9.38
EV/Sales36.01
Price$10.64
Change0.00%
Shares Out224.95M
Market Cap$2.39B
Enterprise Value$1.87B
52W Range6.23 - 16.44
Beta0.94
P/E-7.94
P/S45.98
P/B4.60
P/FCF-9.38
EV/Sales36.01
EV/EBITDA-6.38
EV/FCF-7.35
Earnings Yield-12.59%
FCF Yield-10.66%
Dividend Yield0.00%
Gross Margin87.31%
Oper. Margin-5.21%
Profit Margin-5.13%
Debt/Eq0.12
Current Ratio15.39
Quick Ratio15.32
Revenue 5Y40.31%
Target$27.50
Target Upside158.46%
Target Median$27.50
Target Range25.00 - 30.00
Volume2.18M
Avg Volume2.70M
EPS Surprise-0.09
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
47/100
Why this score▼
Manageable debt level · 0.12Healthy liquidity · 15.39Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 19 analyst votes · 2026-09-05
95/100
Bullish
Bullish
17
Hold
2
Bearish
0
Price Target
2026-08-05
Low
$25.00
Mean
$28.33
Median
$30.00
High
$30.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Williams Leslie J.
Transaction: 06/10/2026
BUY
Change
+44,000
Price
$8.74
Filing
06/12/2026
Type
BUY
Williams Leslie J.
Transaction: 06/10/2026
BUY
Change
+14,000
Price
Not reported
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Dugel Pravin | BUY | +50,092 | Not reported | 06/16/2026 | 06/18/2026 |
| Williams Leslie J. | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| Williams Leslie J. | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| RAINES MERILEE | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| RAINES MERILEE | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| LINDSTROM RICHARD L MD | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| LINDSTROM RICHARD L MD | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| Hong Seung Suh | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| Hong Seung Suh | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| Robins Jason Shand | BUY | +14,024 | $8.74 | 06/10/2026 | 06/12/2026 |
| Robins Jason Shand | BUY | +15,441 | Not reported | 06/10/2026 | 06/12/2026 |
| Graves Adrienne L | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| Graves Adrienne L | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| Warden Charles M | BUY | +44,000 | $8.74 | 06/10/2026 | 06/12/2026 |
| Warden Charles M | BUY | +14,000 | Not reported | 06/10/2026 | 06/12/2026 |
| Waheed Nadia | SELL | -14,828 | $8.27 | 06/03/2026 | 06/05/2026 |
| Dugel Pravin | SELL | -394,696 | Not reported | 05/28/2026 | 05/28/2026 |
| Nayak Sanjay | SELL | -1,858 | $8.20 | 05/26/2026 | 05/28/2026 |
| Heier Jeffrey S. | SELL | -3,018 | $8.20 | 05/26/2026 | 05/28/2026 |
| Kaiser Peter | SELL | -2,967 | $8.20 | 05/26/2026 | 05/28/2026 |